Telix, AU000000TLX2

Telix stock trades at 8.44 euros on Tuesday evening

Published on 11/10/2026 at 20:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Telix develops therapeutic and diagnostic radiopharmaceuticals. Its next shareholder meeting is scheduled for December 1, 2026, in Melbourne and online.

Business focus and next event

  • Telix develops therapeutic and diagnostic radiopharmaceuticals and related medical technologies.
  • The company has scheduled its next general meeting for December 1, 2026, in Melbourne and online.
Telix, AU000000TLX2, Illustration mit AI erstellt.

Telix stock traded at 8.44 euros on Lang & Schwarz at 8:15 p.m. CET on Tuesday, November 10.

Telix is focused on therapeutic and diagnostic radiopharmaceuticals and associated medical technologies, according to the company's investor-relations page.

Business focus and next event

The investor calendar lists a general meeting of shareholders for December 1, 2026, in Melbourne and online. The meeting is the next scheduled shareholder event shown on the company's investor-relations page.

Telix stock at a glance

  • Company: Telix Pharmaceuticals Limited
  • ISIN: AU000000TLX2
  • Trading venue: Lang & Schwarz
  • Stock quote: 8.44 euros
  • Quote time: 8:15 p.m. CET on Tuesday, November 10, 2026

Australian equities are commonly tracked through the S&P/ASX 200.

More news and analyses on Telix stock

Disclaimer...
en | AU000000TLX2 | TELIX | boerse | 70488437 | bgmi